Late Phase Research and Real World Evidence
We help you plan early for long-term commercial success, helping you to mitigate risk and establish evidence.
Accelerated approvals put more pressure on regulatory, risk management, and risk mitigation strategies.
The need has never been greater for healthcare companies to be diligent when it comes to late-phase or peri-approval research. Cerner Enviza ℠ has more than 30 years of clinical research experience and can design a customized study to meet the needs of your product or research area. Our solutions enable you to adhere to risk management requirements, establish evidence for safety issues, and assess health outcomes and economics in various settings.